Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
University of Nebraska-Lincoln Builds Nanoscience Metrology Facility
The University of Nebraska–Lincoln is building the Voelte-Keegan Nanoscience Metrology Facility (NMF). The 32,000-sf facility will provide a temperature-stabilized research environment with minimized vibration and electromagnetic fields. The NMF will include a nanofabrication cleanroom, a materials preparation facility, and laboratories for nanofiber characterization, manufacturing metrology, and nanophotonics.
Dartmouth College Opens Life Sciences Center
Dartmouth College opened the $127.5 million Class of 1978 Life Sciences Center in September of 2011. The facility features interactive classrooms, a 200-seat auditorium, seminar rooms, and a rooftop greenhouse. The construction cost of the facility was $92 million. LEED Platinum sustainable design certification will be sought for the project. The Class of 1978 Life Sciences Center will be dedicated in November of 2011.
Nova Southeastern University Opens Palm Beach Gardens Campus
Nova Southeastern University opened its new campus in Palm Beach Gardens, Fla., in September of 2011. The $17 million, 75,000-sf facility houses 26 classrooms, four labs, six exam rooms, a student lounge, and a fitness center. The four-story building can accommodate community events and includes video conferencing capabilities.
Medicago Opens Vaccine Research and Production Facility
Medicago opened its $32 million Vaccine Research and Production Facility in September of 2011. Located in Research Triangle Park, the 97,000-sf project will support commercial grade production of influenza vaccines using VLP (virus-like particle) plant-based manufacturing technology. The general contractor, KBR Building Group, was awarded a $19 million contract to build the facility in November of 2010. The plant can produce 10 million doses per month and can increase production within three months to respond to an influenza pandemic.
NanoViricides Expands in West Haven
NanoViricides is expanding in West Haven, Conn., with the acquisition of an 18,000-sf facility. The building will house laboratories and a cGMP pilot plant for production of nanoviricide pharmaceutical candidates for clinical trials. NanoViricides is engaged in creating anti-viral drugs for H1N1, H5N1, seasonal influenza, hepatitis, rabies, Dengue fever, and Ebola.